Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-088490)

Filing Details

Accession Number:: 0000950170-25-088490
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-20 16:05:04
Reporting Period:: 2025-06-17

Filing Date:: 2025-06-20
Accepted Time:: 2025-06-20 16:05:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1541157	Akari Therapeutics Plc	AKTX	Pharmaceutical Preparations (2834)	981034922

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2049375	Abizer Gaslightwala	C/O Akari Therapeutics Plc 22 Boston Wharf Road Fl 7 Boston MA 02210	President & Ceo	No	No	No	No

Transaction Summary

Purchased:	15,000 shares	Avg. Price: $1.20	Total Value: $18,000.00
Number of Shares After Transactions:	261,428 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
American Depositary Shares Representing Ordinary Shares	Acquisiton	2025-06-17	15,000	$1.20	261,428	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.